Results 211 to 220 of about 11,056 (236)

Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease. [PDF]

Viruses
Johnson DM, Juelich T, Zhang L, Smith JK, Kalveram BK, Perez D, Smith J, Grimes MR, Garron T, Torres M, Massey S, Brasel T, Beasley DWC, Freiberg AN, Comer JE.   +14 more
europepmc   +1 more source

Process Intensification for Recombinant Marburg Virus Glycoprotein Production Using <i>Drosophila</i> S2 Cells. [PDF]

Eng Life Sci
Göbel S, Mayerlen L, Eiser IY, Fichtmueller L, Clements D, Reichl U, Genzel Y, Lehrer A.   +7 more
europepmc   +1 more source

Prevalence of somatic symptoms among Ebola Virus Disease (EVD) survivors in Africa: a systematic review and meta-analysis. [PDF]

BMC Public Health
Mandizadza OO, Phebeni RT, Ji C.
europepmc   +1 more source

Development of a Měnglà virus minigenome and comparison of its polymerase complexes with those of other filoviruses. [PDF]

Virol Sin
Xie SZ, Yao K, Li B, Peng C, Yang XL, Shi ZL.   +5 more
europepmc   +1 more source

Nano-Biomechanical Investigation of Phosphatidylserine-Mediated Ebola Viral Attachment via Human Gas6 and Axl. [PDF]

Viruses
Hou D, Mu Q, Chen W, Cao W, Zhang XF.
europepmc   +1 more source

Bioinformatic Tools for Studying the Cellular Immune Response to SARS-CoV-2, Vaccine Efficacy, and Future Pandemics at the Global Population Level. [PDF]

Int J Mol Sci
López D, Zumárraga J.
europepmc   +1 more source

A broadly-neutralizing antibody againstEbolavirusglycoprotein that potentiates the breadth and neutralization potency of other antibodies

Donnellan FR, Rayaprolu V, Rijal P, O’Dowd V, Parvate A, Callaway H, Hariharan C, Parekh D, Hui S, Shaffer K, Avalos RD, Hastie K, Schimanski L, Müller-Kräuter H, Strecker T, Balaram A, Halfmann P, Saphire EO, Lightwood DJ, Townsend AR, Draper SJ.   +20 more
europepmc   +1 more source